The research conducted by Anita A. Wasik and Tamara Tuuminen explores the effectiveness of salt therapy, particularly halotherapy, as a complementary treatment for respiratory diseases, with a focus on conditions linked to mold-related illnesses. Salt therapy, which includes methods like speleotherapy (breathing in the air of salt caves) and halotherapy (controlled inhalation of sodium chloride aerosol), has a long history dating back to the 19th century in Europe and Russia. The study highlights the therapeutic benefits of inhaling sodium chloride aerosol in a controlled environment with specific temperature and humidity conditions. These salt particles, which penetrate all layers of the respiratory tract, are known for their antibacterial, anti-inflammatory, and mucociliary properties. The therapy helps to clear mucus, reduce inflammation, and improve overall respiratory function.
The study supports the clinical efficacy of salt therapy in managing various respiratory conditions such as chronic bronchitis, sinusitis, asthma, bronchiectasis, and chronic obstructive pulmonary disease (COPD). It also finds that salt therapy is beneficial for patients exposed to mold-related indoor air microbiota, which can cause damage to the respiratory mucosa. Salt therapy’s positive effects extend beyond symptom relief, as it helps to reduce immunoglobulin E (IgE) levels, which are associated with allergic reactions. Furthermore, the research emphasizes that salt therapy is safe, well-tolerated, and can be a valuable complementary treatment for respiratory diseases, particularly in cases of chronic inflammation or prolonged exposure to environmental irritants like mold.
